Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nikolaos Perakakis

Showing results (11-20 of 67) with videos related to

Pageof 7
Sort By:
Lipids in Health and Disease|December 16, 2022
PCSK9 inhibition and cholesterol homeostasis in insulin producing β-cellsGünter Päth, Nikolaos Perakakis, Christos S Mantzoros, et al.
Metabolism: Clinical and Experimental|October 21, 2018
Stem cells in the treatment of diabetes mellitus - Focus on mesenchymal stem cellsGünter Päth, Nikolaos Perakakis, Christos S Mantzoros, et al.
The Medical Clinics of North America|November 21, 2017
Obesity as a DiseaseJagriti Upadhyay, Olivia Farr, Nikolaos Perakakis, et al.
Obesity Reviews : an Official Journal of the International Association for the Study of Obesity|August 8, 2023
Liver fat as risk factor of hepatic and cardiometabolic diseasesMünevver Demir, Stefan R Bornstein, Christos S Mantzoros, et al.
Metabolism: Clinical and Experimental|August 1, 2024
Regional gray matter changes in steatotic liver disease provide a neurobiological link to depression: A cross-sectional UK Biobank cohort studyDominic Arold, Stefan R Bornstein, Nikolaos Perakakis, et al.
International Journal of Molecular Sciences|July 2, 2021
Empagliflozin Improves Metabolic and Hepatic Outcomes in a Non-Diabetic Obese Biopsy-Proven Mouse Model of Advanced NASHNikolaos Perakakis, Pavlina Chrysafi, Michael Feigh, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|March 31, 2021
Elafibranor and liraglutide improve differentially liver health and metabolism in a mouse model of non-alcoholic steatohepatitisNikolaos Perakakis, Konstantinos Stefanakis, Michael Feigh, et al.
Clinical Nutrition (Edinburgh, Scotland)|February 5, 2021
Branched-Chain Amino Acids in relation to food preferences and insulin resistance in obese subjects consuming walnuts: A cross-over, randomized, double-blind, placebo-controlled inpatient physiology studyDario Tuccinardi, Nikolaos Perakakis, Olivia M Farr, et al.
Cardiovascular Diabetology|November 2, 2019
Short-term treatment with high dose liraglutide improves lipid and lipoprotein profile and changes hormonal mediators of lipid metabolism in obese patients with no overt type 2 diabetes mellitus: a randomized, placebo-controlled, cross-over, double-blind clinical trialNatia Peradze, Olivia M Farr, Nikolaos Perakakis, et al.
Discover Mental Health|March 7, 2022
The interface of COVID-19, diabetes, and depressionCharlotte Steenblock, Peter E H Schwarz, Nikolaos Perakakis, et al.
Pageof 7

Showing results (11-20 of 67) with videos related to

Sort By:
Pageof 7
Lipids in Health and Disease|December 16, 2022
PCSK9 inhibition and cholesterol homeostasis in insulin producing β-cellsGünter Päth, Nikolaos Perakakis, Christos S Mantzoros, et al.
Metabolism: Clinical and Experimental|October 21, 2018
Stem cells in the treatment of diabetes mellitus - Focus on mesenchymal stem cellsGünter Päth, Nikolaos Perakakis, Christos S Mantzoros, et al.
The Medical Clinics of North America|November 21, 2017
Obesity as a DiseaseJagriti Upadhyay, Olivia Farr, Nikolaos Perakakis, et al.
Obesity Reviews : an Official Journal of the International Association for the Study of Obesity|August 8, 2023
Liver fat as risk factor of hepatic and cardiometabolic diseasesMünevver Demir, Stefan R Bornstein, Christos S Mantzoros, et al.
Metabolism: Clinical and Experimental|August 1, 2024
Regional gray matter changes in steatotic liver disease provide a neurobiological link to depression: A cross-sectional UK Biobank cohort studyDominic Arold, Stefan R Bornstein, Nikolaos Perakakis, et al.
International Journal of Molecular Sciences|July 2, 2021
Empagliflozin Improves Metabolic and Hepatic Outcomes in a Non-Diabetic Obese Biopsy-Proven Mouse Model of Advanced NASHNikolaos Perakakis, Pavlina Chrysafi, Michael Feigh, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|March 31, 2021
Elafibranor and liraglutide improve differentially liver health and metabolism in a mouse model of non-alcoholic steatohepatitisNikolaos Perakakis, Konstantinos Stefanakis, Michael Feigh, et al.
Clinical Nutrition (Edinburgh, Scotland)|February 5, 2021
Branched-Chain Amino Acids in relation to food preferences and insulin resistance in obese subjects consuming walnuts: A cross-over, randomized, double-blind, placebo-controlled inpatient physiology studyDario Tuccinardi, Nikolaos Perakakis, Olivia M Farr, et al.
Cardiovascular Diabetology|November 2, 2019
Short-term treatment with high dose liraglutide improves lipid and lipoprotein profile and changes hormonal mediators of lipid metabolism in obese patients with no overt type 2 diabetes mellitus: a randomized, placebo-controlled, cross-over, double-blind clinical trialNatia Peradze, Olivia M Farr, Nikolaos Perakakis, et al.
Discover Mental Health|March 7, 2022
The interface of COVID-19, diabetes, and depressionCharlotte Steenblock, Peter E H Schwarz, Nikolaos Perakakis, et al.
Pageof 7